PLATELET-ADHESION ONTO ARTIFICIAL SURFACES - INHIBITION BY BENZAMIDINE, PENTAMIDINE, AND PYRIDOXAL-5-PHOSPHATE AS DEMONSTRATED BY FLOW CYTOMETRIC QUANTIFICATION OF PLATELET-ADHESION TO MICROSPHERES
Ch. Gemmell, PLATELET-ADHESION ONTO ARTIFICIAL SURFACES - INHIBITION BY BENZAMIDINE, PENTAMIDINE, AND PYRIDOXAL-5-PHOSPHATE AS DEMONSTRATED BY FLOW CYTOMETRIC QUANTIFICATION OF PLATELET-ADHESION TO MICROSPHERES, The Journal of laboratory and clinical medicine, 131(1), 1998, pp. 84-92
Citations number
32
Categorie Soggetti
Medicine, General & Internal","Medicine, Research & Experimental
An appreciable effort is directed toward designing strategies to minim
ize platelet interactions with artificial surfaces, because their reac
tivity is thought to promote thrombus formation and lead to materials
failure. Although platelet glycoprotein Ib/IX (GPIb/IX) and glycoprote
in IIb/IIa (GPIIb/IIIa) receptors are thought to mediate adhesion, whe
ther GPIIb/IIIa receptors are activated and how this might occur are l
argely unknown and are the focus of this article. There are a few ways
, other than thrombin generation, that blood contact with artificial s
urfaces can lead to GPIIb/IIIa activation. Complement activation can l
ead to products capable of activating platelets (C1q, C5b-9), and cont
act between platelet CD32 (Fc gamma RII) receptors and immobilized imm
unoglobulin G could also activate platelets. In this article the poten
tial role of these processes was evaluated by using various inhibitors
in a microsphere-based platelet adhesion immunoassay. Polystyrene mic
rospheres (10 mu m) were incubated in platelet-rich plasma before flow
cytometric analysis of beads for adherent platelets. The data elimina
ted occupancy of the Fc gamma RII receptor (by use of IV.3 blocking an
tibody), C5b-9 production (by use of sCR1), and the indirect action of
factor XIIa on complement components (by use of corn trypsin inhibito
r) as playing roles in supporting platelet adhesion. Agents directed a
gainst the first complement component (benzamidine, pentamidine, pyrid
oxal-5-phosphate) were effective inhibitors of platelet adhesion and w
ere also demonstrated to inhibit SC5b-9 and C3d levels on the bead sur
face after serum incubations. Because these agents are not highly spec
ific, it can not be concluded that Clq is a mediator of adhesion. Thes
e agents were also demonstrated to inhibit fluorescein isothiocyanate-
fibrinogen binding to activated washed platelets, therefore indicating
that fibrinogen receptor expression is a requirement for platelet adh
esion.